From H+Pedia
Revision as of 18:37, 26 May 2023 by Devbret (talk | contribs) (Added a reference link to to help validate that BioViva is a company located in the Seattle Metro Area, working to slow the aging process in humans.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

BioViva is a Seattle based biotech company working on treatments to slow the ageing process in humans.[1]


In September 2015, CEO Liz Parrish flew to Colombia to receive two experimental gene therapies. One was a myostatin inhibitor, a drug that is being tested as a treatment for muscle loss. The other was a telomerase gene therapy, the drug that BioViva claims has reversed her cells' biological age, by lengthening parts of her genetic material called telomeres.[2]

If early data is accurate, it is the world's first successful example of telomere lengthening via gene therapy in a human individual.[3]

The organization is owned by umbrella company BioTrove Investments.


The treatment as well as the self-experimentation is highly controversial. Because the necessary pre-clinical work to progress to human studies, the US Food and Drug Administration did not authorise Parrish's experiment, requiring her to travel for treatment.

Timothy Caulfield, professor in the Faculty of Law and the School of Public Health at the University of Alberta characterising BioViva's work as 'Pseudo-science' and lacking scientific rigour. George M Martin, professor of pathology at the University of Washington had agreed to be an adviser to the company but resigned on hearing about the self-experiment.[2]

External Links